Evaluation method of cholesterol-lowering agents lack rationale, civic groups say

Civic groups advocating consumer rights, including the Korean Pharmacists for Democratic Society (KPRS), said in a recent statement that Pfizer and AstraZeneca profiteered 30.7 billion won due to the Health Insurance Review and Assessment Service’s biased cost-effectiveness evaluation on Lipitor and Crestor.

The state said that the HIRA’s decision has forced consumers to shoulder the growing...